These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 36678684)
1. Consideration of Commercially Available Hepatocytes as Cell Sources for Liver-Microphysiological Systems by Comparing Liver Characteristics. Horiuchi S; Kuroda Y; Komizu Y; Ishida S Pharmaceutics; 2022 Dec; 15(1):. PubMed ID: 36678684 [TBL] [Abstract][Full Text] [Related]
2. Drug metabolizing enzyme and transporter protein profiles of hepatocytes derived from human embryonic and induced pluripotent stem cells. Ulvestad M; Nordell P; Asplund A; Rehnström M; Jacobsson S; Holmgren G; Davidson L; Brolén G; Edsbagge J; Björquist P; Küppers-Munther B; Andersson TB Biochem Pharmacol; 2013 Sep; 86(5):691-702. PubMed ID: 23856292 [TBL] [Abstract][Full Text] [Related]
3. Critical differences in toxicity mechanisms in induced pluripotent stem cell-derived hepatocytes, hepatic cell lines and primary hepatocytes. Sjogren AK; Liljevald M; Glinghammar B; Sagemark J; Li XQ; Jonebring A; Cotgreave I; Brolén G; Andersson TB Arch Toxicol; 2014 Jul; 88(7):1427-37. PubMed ID: 24912781 [TBL] [Abstract][Full Text] [Related]
4. Human-Induced Pluripotent Stem Cell-Derived Hepatocytes and their Culturing Methods to Maintain Liver Functions for Pharmacokinetics and Safety Evaluation of Pharmaceuticals. Inoue T; Iwazaki N; Araki T; Hitotsumachi H Curr Pharm Biotechnol; 2020; 21(9):773-779. PubMed ID: 32003687 [TBL] [Abstract][Full Text] [Related]
5. Characterization of rat or human hepatocytes cultured in microphysiological systems (MPS) to identify hepatotoxicity. Chang SY; Voellinger JL; Van Ness KP; Chapron B; Shaffer RM; Neumann T; White CC; Kavanagh TJ; Kelly EJ; Eaton DL Toxicol In Vitro; 2017 Apr; 40():170-183. PubMed ID: 28089783 [TBL] [Abstract][Full Text] [Related]
6. Aquaporin 9 induction in human iPSC-derived hepatocytes facilitates modeling of ornithine transcarbamylase deficiency. Laemmle A; Poms M; Hsu B; Borsuk M; Rüfenacht V; Robinson J; Sadowski MC; Nuoffer JM; Häberle J; Willenbring H Hepatology; 2022 Sep; 76(3):646-659. PubMed ID: 34786702 [TBL] [Abstract][Full Text] [Related]
7. Successful energy shift from glycolysis to mitochondrial oxidative phosphorylation in freshly isolated hepatocytes from humanized mice liver. Ikeyama Y; Sato T; Takemura A; Sekine S; Ito K Toxicol In Vitro; 2020 Jun; 65():104785. PubMed ID: 31991145 [TBL] [Abstract][Full Text] [Related]
8. Chemically induced hepatotoxicity in human stem cell-induced hepatocytes compared with primary hepatocytes and HepG2. Kang SJ; Lee HM; Park YI; Yi H; Lee H; So B; Song JY; Kang HG Cell Biol Toxicol; 2016 Oct; 32(5):403-17. PubMed ID: 27287938 [TBL] [Abstract][Full Text] [Related]
9. 3D microperfusion of mesoscale human microphysiological liver models improves functionality and recapitulates hepatic zonation. Wesseler MF; Taebnia N; Harrison S; Youhanna S; Preiss LC; Kemas AM; Vegvari A; Mokry J; Sullivan GJ; Lauschke VM; Larsen NB Acta Biomater; 2023 Nov; 171():336-349. PubMed ID: 37734628 [TBL] [Abstract][Full Text] [Related]
10. NADPH-cytochrome P450 reductase expression and enzymatic activity in primary-like human hepatocytes and HepG2 cells for in vitro biotransformation studies. Schulz C; Kammerer S; Küpper JH Clin Hemorheol Microcirc; 2019; 73(1):249-260. PubMed ID: 31561354 [TBL] [Abstract][Full Text] [Related]
11. A transcriptomic study suggesting human iPSC-derived hepatocytes potentially offer a better in vitro model of hepatotoxicity than most hepatoma cell lines. Gao X; Liu Y Cell Biol Toxicol; 2017 Aug; 33(4):407-421. PubMed ID: 28144825 [TBL] [Abstract][Full Text] [Related]
12. Integrated Isogenic Human Induced Pluripotent Stem Cell-Based Liver and Heart Microphysiological Systems Predict Unsafe Drug-Drug Interaction. Lee-Montiel FT; Laemmle A; Charwat V; Dumont L; Lee CS; Huebsch N; Okochi H; Hancock MJ; Siemons B; Boggess SC; Goswami I; Miller EW; Willenbring H; Healy KE Front Pharmacol; 2021; 12():667010. PubMed ID: 34025426 [TBL] [Abstract][Full Text] [Related]
13. Propagation of Human Hepatocytes in uPA/SCID Mice: Producing Chimeric Mice with Humanized Liver. Ohshita H; Tateno C Methods Mol Biol; 2017; 1506():91-100. PubMed ID: 27830547 [TBL] [Abstract][Full Text] [Related]
14. Coculture with hiPS-derived intestinal cells enhanced human hepatocyte functions in a pneumatic-pressure-driven two-organ microphysiological system. Shinohara M; Arakawa H; Oda Y; Shiraki N; Sugiura S; Nishiuchi T; Satoh T; Iino K; Leo S; Kato Y; Araya K; Kawanishi T; Nakatsuji T; Mitsuta M; Inamura K; Goto T; Shinha K; Nihei W; Komori K; Nishikawa M; Kume S; Kato Y; Kanamori T; Sakai Y; Kimura H Sci Rep; 2021 Mar; 11(1):5437. PubMed ID: 33686099 [TBL] [Abstract][Full Text] [Related]
15. Exosomes from Human-Induced Pluripotent Stem Cell-Derived Mesenchymal Stromal Cells (hiPSC-MSCs) Protect Liver against Hepatic Ischemia/ Reperfusion Injury via Activating Sphingosine Kinase and Sphingosine-1-Phosphate Signaling Pathway. Du Y; Li D; Han C; Wu H; Xu L; Zhang M; Zhang J; Chen X Cell Physiol Biochem; 2017; 43(2):611-625. PubMed ID: 28934733 [TBL] [Abstract][Full Text] [Related]
16. Gut-liver microphysiological systems revealed potential crosstalk mechanism modulating drug metabolism. Kurniawan DA; Leo S; Inamatsu M; Funaoka S; Aihara T; Aiko M; Rei I; Sakura T; Arakawa H; Kato Y; Matsugi T; Esashika K; Shiraki N; Kume S; Shinha K; Kimura H; Nishikawa M; Sakai Y PNAS Nexus; 2024 Feb; 3(2):pgae070. PubMed ID: 38384383 [TBL] [Abstract][Full Text] [Related]
17. Microphysiological systems meet hiPSC technology - New tools for disease modeling of liver infections in basic research and drug development. Raasch M; Fritsche E; Kurtz A; Bauer M; Mosig AS Adv Drug Deliv Rev; 2019 Feb; 140():51-67. PubMed ID: 29908880 [TBL] [Abstract][Full Text] [Related]